Trial Profile
Phase 3 Study of AK156 in Primary Osteoporosis Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Nov 2021
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Osteoporosis; Vertebral fracture
- Focus Therapeutic Use
- Acronyms ZONE
- Sponsors Asahi Kasei
- 01 Dec 2021 Results of sub-analysis of this study published in the Calcified Tissue International.
- 01 Oct 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.